FFL Partners has invested in Apex Infusion, a growing provider of ambulatory infusion therapy services.

Founded in 2006, Apex provides intravenous immunoglobulin, specialty infusion, total parental nutrition and other therapeutic services throughout 11 locations in California.

“We believe there’s a significant greenfield de novo and acquisition opportunity, and we expect to deploy more capital to support Apex’s M&A strategy,” says FFL Partners Managing Partner Chris Harris.